USFK Emergency... One KATUSA Vaccinated with Janssen Tests Positive for COVID-19

South Korean Soldier Confirmed Positive Less Than a Month After Vaccination
Cumulative Confirmed Cases Related to USFK Reach 848

[Image source=Yonhap News]

[Asia Economy Reporter Onyu Lim] It has been confirmed that one Korean soldier serving in the U.S. Forces Korea, known as a 'KATUSA,' tested positive for COVID-19 after receiving the vaccine.

The U.S. Forces Korea Command announced on the 1st that a KATUSA serving at Camp Casey, a U.S. military base in Dongducheon, Gyeonggi Province, tested positive during a test conducted before returning from leave on the 29th of last month.

The confirmed patient is currently receiving treatment at a COVID-19 isolation facility within Camp Humphreys (Pyeongtaek).

It is known that the confirmed patient received the Johnson & Johnson Janssen vaccine, which is administered as a single dose, at a hospital within the U.S. military base in early last month. The patient tested positive for COVID-19 less than a month after vaccination.

The military and quarantine authorities are also analyzing information shared by the U.S. Forces Korea regarding re-infection cases and adverse reaction reports among KATUSAs and Korean civilian employees who received the vaccine, including this case.

As of this date, the cumulative number of confirmed COVID-19 cases related to the U.S. Forces Korea has reached 848.

Meanwhile, the U.S. Forces Korea, which introduced the Moderna and Janssen vaccines, recently temporarily suspended Janssen vaccinations due to concerns over the occurrence of 'rare thrombosis.' However, following recommendations from the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), vaccine use resumed from the day before.

This content was produced with the assistance of AI translation services.